Hybrid model has its good and bad points
Roche is a solid global pharma company with a stable environment, but work flexibility can be hit or miss depending on your team and role.
I liked the option for a hybrid model; sometimes I could work from home two days a week. For a Clinical Research Associate, that's pretty decent in the pharma industry, especially if you're not always needing to be in the lab. The South San Francisco office is well-equipped for days you are onsite.
The hybrid policy isn't consistent across all departments. Some teams, particularly those in drug development, still expect almost full-time onsite presence which makes planning tough. It's not truly flexible if your manager dictates every onsite day, even within the hybrid framework.
Standardize the hybrid work policy across all divisions and roles where it's feasible. True flexibility would boost morale and retain talent, especially in competitive markets like the South San Francisco Bay Area.